Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma

Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report

(2016) SOTIRIOS SACHANAS et al.   ANTICANCER RESEARCH

AtypicalPneumocystis jiroveciipneumonia in previously untreated patients with CLL on single-agent ibrutinib

(2016) Inhye E. Ahn et al.   BLOOD

Idelalisib-related pneumonitis

(2016) Eglantine Haustraete et al.   EUROPEAN RESPIRATORY JOURNAL

X-linked Agammaglobulinemia

(2016) Deepti Suri et al.   INDIAN JOURNAL OF PEDIATRICS

Decrease in total protein level of Bruton’s tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes

(2016) F Cervantes-Gomez et al.   LEUKEMIA

State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia

(2016) Paula Cramer et al.   Oncology Research and Treatment

Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia

(2015) Song-Yau Wang et al.   ANNALS OF HEMATOLOGY

Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia

(2015) A. R. Mato et al.   BLOOD

Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib

(2015) J. C. Byrd et al.   BLOOD

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

(2015) C. Sun et al.   BLOOD

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

(2015) R. A. de Claro et al.   CLINICAL CANCER RESEARCH

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia

(2015) Kami J. Maddocks et al.   JAMA Oncology

Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia

(2013) Jacqueline Barrientos et al.   LEUKEMIA & LYMPHOMA

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

(2013) John C. Byrd et al.   NEW ENGLAND JOURNAL OF MEDICINE